Component
Pharmacologically PKA-inhibited human neutrophil state
Experimental PKA inhibitor condition; not a human nutrient deficiency or genetic disease state.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Adding a PKA inhibitor weakened 6-gingerol suppression of APS-IgG-triggered NETosis in human neutrophils.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- dose
- 6-Gingerol with APS IgG and PKA inhibitor; exact inhibitor dose not specified in inspected text
- duration
- 3 h NETosis assay
- evidence_access
- Primary open full text, results, figure legends and methods, plus PubMed metadata.
- evidence_scope
- literature_reviewed; model-specific source-derived curation, not universally established human effects
- experimental_model
- Human donor neutrophils with pharmacologically inhibited PKA
- limitations
- Supports a PKA-sensitive component; pharmacological inhibition is not selective genetic deletion or a nutrient deficiency.
- nutrient_topic
- Gingerols collection; each molecular form and experimental preparation remains explicit. · Gingerols
- organism
- Human donor neutrophils with pharmacologically inhibited PKA
- plain_language
- Adding a PKA inhibitor weakened 6-gingerol suppression of APS-IgG-triggered NETosis in human neutrophils.
- primary_references
- Antineutrophil properties of natural gingerols in models of lupus. (2021). https://pubmed.ncbi.nlm.nih.gov/33373329/ DOI: 10.1172/jci.insight.138385
- route
- Ex vivo co-exposure
- tissue
- Human neutrophils
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Gingerols: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 481–490
Original AI-assisted curation of thirteen primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Human donor neutrophils with pharmacologically inhibited PKA · source_derived_draft · unverified_draft
## gingerols-pka-blockade Adding a PKA inhibitor weakened 6-gingerol suppression of APS-IgG-triggered NETosis in human neutrophils. Model/species: Human donor neutrophils with pharmacologically inhibited PKA Tissue: Human neutrophils Exposure: 6-Gingerol with APS IgG and PKA inhibitor; exact inhibitor dose not specified in inspected text Route: Ex vivo co-exposure Duration: 3 h NETosis assay Limits: Supports a PKA-sensitive component; pharmacological inhibition is not selective genetic deletion or a nutrient deficiency. Primary reference: Antineutrophil properties of natural gingerols in models of lupus. (2021). https://pubmed.ncbi.nlm.nih.gov/33373329/ DOI: 10.1172/jci.insight.138385 Access: Primary open full text, results, figure legends and methods, plus PubMed metadata.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.